tirzepatide phase 3 monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled trial (SURPASS-CN-MONO) Tirzepatide and Retatrutide Revolutionize Diabetes
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20


























